In this episode, Nico Misleh discusses the critical role of thyroid in hormone replacement therapy (HRT), emphasizing that thyroid should not be viewed as an adjunct but as a foundational component. He critiques the conventional approach of using T4 monotherapy for hypothyroidism, highlighting the limitations of TSH as a diagnostic marker. Misleh advocates for combination therapy using T3 and T4, supported by recent studies showing its effectiveness in reducing risks of dementia and mortality. He encourages healthcare providers to adopt a pro-metabolic lens and to empower patients by moving away from outdated practices.Chapters00:00 The Importance of Thyroid in Hormone Replacement Therapy02:50 Monotherapy vs Combination Therapy for Hypothyroidism06:11 Understanding TSH and Its Limitations08:57 The Risks of T4 Monotherapy11:57 The Case for Combination Therapy14:47 Pro-Metabolic Lens on Thyroid Function18:10 The Role of T3 in Metabolism20:58 Empowering Patients and Providers24:03 Creating a New Standard in Thyroid TreatmentFor practitioners who want to confidently grow their practice with guidance in TRT, HRT, and business strategy, find us below:- Nico's Daily Newsletter: ⁠⁠https://nicomislenp.kit.com/8050eeea5f⁠⁠(yes, it's daily... and yes, people stay subscribed)- Join HRT University: https:https://bit.ly/4twBb0D- Join the HRT University Facebook Group: ⁠⁠https://www.facebook.com/groups/1179376819949373/?ref=share&_rdr